GO
Loading...

Roche Holding AG

More

  • Europe shares close down after disappointing earnings Thursday, 25 Jul 2013 | 11:30 AM ET

    European shares closed lower on Thursday with investor confidence curbed by a mixed bag of earnings from major companies and concerns about slowing growth in China.

  • Daniel O'Day, CEO of Roche, talks about the company's results for the first half of the year and sales of its new breast cancer drugs.

  • Roche Pharma CEO on Alexion deal rumors     Thursday, 25 Jul 2013 | 2:25 AM ET

    Daniel O'Day, CEO of Roche's pharma unit, declines to comment on Alexion deal talks, but says the company is keen on incorporating innovations into its portfolio.

  • Roche declines to stamp out Alexion deal rumors Thursday, 25 Jul 2013 | 1:20 AM ET

    Daniel O'Day, the CEO of Roche's pharmaceuticals unit declined to comment on market rumors that the Swiss drug maker is about to bid for Alexion, but told CNBC that the company continues to look for new innovations.

  • Novartis will remain under pressure: pro     Wednesday, 17 Jul 2013 | 3:30 AM ET

    Andrew Weiss, head of pharma and biotech research at Vontobel, , talks about Novartis' quarterly results and outlook and says the company will remain under pressure for the next few quarters.

  • Prognosis: Healthy earnings for pharma, biotech Tuesday, 16 Jul 2013 | 5:46 PM ET
    A doctor checks a patient who is experiencing flu symptoms.

    Pharmaceutical and biotech stocks have outperformed markets this year, and with J&J's second-quarter earnings beat, investors may hope earnings will push stocks even higher.

  • Early movers: LEAP, DELL, BA, GE, R & more Monday, 15 Jul 2013 | 7:33 AM ET

    Some of the names on the move ahead of the open.

  • Bidding Up the Price of Cancer Cures Monday, 1 Jul 2013 | 4:26 PM ET
    Dr. Tony Coles, Chairman & CEO of Onyx

    Amgen's low-ball offer to Onyx Pharmaceuticals has set off speculation of a potential bidding war that could leave another company walking away with Onyx.

  • Bristol and Merck Shares Surge on Cancer Drug News Monday, 3 Jun 2013 | 3:32 PM ET

    Bristol-Myers Squibb and Merck stocks climbed higher Monday as analysts said billions stood to be made from treatment breakthroughs.

  • ASCO: 'Building Bridges to Conquer Cancer'     Monday, 3 Jun 2013 | 7:13 AM ET

    Hal Barron, Roche/Genentech chief medical officer, shares several new developments in treating cancer, including some promising results with Roche/Genentech 's Avastin.

  • Stocks to Watch at This Year's Biotech Super Bowl Friday, 31 May 2013 | 6:21 AM ET
    Merck lab

    The spotlight at this year's American Society of Clinical Oncologists meeting will be on data from Bristol-Myers Squibb, Roche, and Merck on a new class of cancer drugs.

  • Europe Shares Close Higher as Risk-On Rally Resumes Wednesday, 15 May 2013 | 11:07 AM ET

    European shares were higher in early afternoon trade on Wednesday despite preliminary growth data from the euro zone missing estimates.

  • European shares closed sharply higher on Tuesday after a positive Spanish bond auction and better-than-expected French manufacturing data buoyed investor sentiment.

  • Life Tech in $13.6 Billion Buyout by Thermo Fisher Monday, 15 Apr 2013 | 8:01 AM ET
    Thermo Fisher is an American precision healthcare equipment company.

    Genetic testing equipment maker Life Technologies has agreed to a $13.6 billion cash buyout by Thermo Fisher Scientific, in one of the year's biggest corporate takeovers.

  • European Stocks Close Higher After US Data Thursday, 11 Apr 2013 | 11:33 AM ET

    European shares closed higher on Thursday after better-than-expected initial jobless claims data from the U.S. The numbers are important as a key metric for Fed policy makers, who have said they could taper off asset purchases once the labor market improves.

  • Tamiflu and Cancer Drugs Boost Roche     Thursday, 11 Apr 2013 | 3:30 AM ET

    Daniel O'Day, head of pharmaceutical operations at Roche, tells CNBC that the company haven't seen a huge effect from the Sequester in the US.

  • Roche Results Better Than Expected: Pro     Thursday, 11 Apr 2013 | 3:15 AM ET

    Andrew Weiss, head of Pharma at Vontobel, tells CNBC that Roche delivered earnings in line with expectations.

  • China Rolls Up Sleeves in Fight Against Bird Flu Friday, 5 Apr 2013 | 12:32 AM ET

    China said it was mobilizing resources nationwide to combat a new strain of bird flu that has killed six people, as Japan, Hong Kong and the United States stepped up vigilance.

  • Cramer: Investing in Future of Cancer Drugs Thursday, 4 Apr 2013 | 6:28 PM ET

    At least three companies are on the cutting edge of new treatments for perhaps the most feared disease known to mankind.

  • New Bird Flu Cases Rise in China, Three Deaths Wednesday, 3 Apr 2013 | 8:21 PM ET

    China has found two more cases of a new strain of bird flu and one of the victims has died, bringing to nine the number of confirmed human infections from the previously unknown flu type.

Most Popular Video

Thursday, 17 Apr 2014 | 5:00 AM ET

Today is CNBC's 25th anniversary. There have been a lot of great moments in the network's history. Here are just a few.

Thursday, 17 Apr 2014 | 3:15 AM ET

Jonny Forsyth, global drinks analyst at Mintel, says China has been a "cash cow" for drink-makers, but the slowdown is having a big impact on sales.

Thursday, 17 Apr 2014 | 1:35 AM ET

CNBC's Helia Ebrahimi discusses the Co-Operative's troubled story from drug buying allegations against the former chairman, to big financial black holes.